$AKTSQ
Akoustis Technologies, Inc. Stock $aktsq

$aktsq Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-K Financial Statement

#000121390024085984 Filed on October 08, 2024

Income Statement

Concept	2024 Q4	2024 Q2	2024
Revenue		$5.855M	$27.38M
YoY Change		-29.74%	0.97%
Cost Of Revenue		$6.490M	$28.07M
YoY Change		-35.34%	-7.16%
Gross Profit		-$635.0K	-$689.0K
YoY Change		-62.73%	-77.89%
Gross Profit Margin		-10.85%	-2.52%
Selling, General & Admin		$7.431M	$35.88M
YoY Change		-7.8%	20.78%
% of Gross Profit
Research & Development		$7.260M	$29.99M
YoY Change		-11.07%	-9.79%
% of Gross Profit
Depreciation & Amortization		$3.267M	$10.10M
YoY Change		6.66%	-10.27%
% of Gross Profit
Operating Expenses		$14.69M	$109.3M
YoY Change		-9.45%	73.62%
Operating Profit		-$15.33M	-$110.0M
YoY Change		-14.51%	66.48%
Interest Expense		-$728.0K	-$579.0K
YoY Change		-682.4%	-57.86%
% of Operating Profit
Other Income/Expense, Net		$4.000K	-$57.95M
YoY Change		-60.0%	-90651.56%
Pretax Income		-$108.8M	-$167.9M
YoY Change		511.49%	154.44%
Income Tax		$1.000K	$6.000K
% Of Pretax Income
Net Earnings		-$108.8M	-$168.0M
YoY Change		512.46%	164.25%
Net Earnings / Revenue		-1858.29%	-613.31%
Basic Earnings Per Share			-$1.89
Diluted Earnings Per Share		-$0.91	-$1.89
COMMON SHARES
Basic Shares Outstanding	154.6M shares	98.67M shares	89.09M shares
Diluted Shares Outstanding			89.09M shares

Balance Sheet

Concept	2024 Q2	2024
SHORT-TERM ASSETS
Cash & Short-Term Investments	$24.45M	$24.45M
YoY Change	-43.28%	-43.28%
Cash & Equivalents	$24.40M	$24.45M
Short-Term Investments
Other Short-Term Assets	$2.991M	$1.607M
YoY Change	-32.64%	-63.81%
Inventory	$2.223M	$2.223M
Prepaid Expenses
Receivables	$3.911M	$5.295M
Other Receivables	$3.197M	$3.197M
Total Short-Term Assets	$36.77M	$36.77M
YoY Change	-38.56%	-38.56%
LONG-TERM ASSETS
Property, Plant & Equipment	$12.91M	$13.83M
YoY Change	-77.68%	-76.64%
Goodwill	$6.500M
YoY Change	-55.35%
Intangibles	$12.57M
YoY Change	-17.56%
Long-Term Investments
YoY Change
Other Assets	$71.00K	$71.00K
YoY Change	-1.39%	-1.39%
Total Long-Term Assets	$32.97M	$32.97M
YoY Change	-62.98%	-62.98%
TOTAL ASSETS
Total Short-Term Assets	$36.77M	$36.77M
Total Long-Term Assets	$32.97M	$32.97M
Total Assets	$69.74M	$69.74M
YoY Change	-53.17%	-53.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.998M	$3.998M
YoY Change	0.48%	0.48%
Accrued Expenses	$12.87M	$12.87M
YoY Change	-4.59%	-4.59%
Deferred Revenue	$131.0K
YoY Change	24.76%
Short-Term Debt	$10.00M	$10.00M
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$84.37M	$84.37M
YoY Change	380.16%	380.16%
LONG-TERM LIABILITIES
Long-Term Debt	$41.89M	$41.89M
YoY Change	-4.83%	-4.83%
Other Long-Term Liabilities	$117.0K	$579.0K
YoY Change	-89.3%	-47.03%
Total Long-Term Liabilities	$42.47M	$42.47M
YoY Change	-5.85%	-5.85%
TOTAL LIABILITIES
Total Short-Term Liabilities	$84.37M	$84.37M
Total Long-Term Liabilities	$42.47M	$42.47M
Total Liabilities	$126.8M	$126.8M
YoY Change	102.36%	102.36%
SHAREHOLDERS EQUITY
Retained Earnings	-$438.5M
YoY Change	62.2%
Common Stock	$123.0K
YoY Change	70.83%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$57.09M	-$57.09M
YoY Change
Total Liabilities & Shareholders Equity	$69.74M	$69.74M
YoY Change	-53.17%	-53.17%

Cashflow Statement

Concept	2024 Q2	2024
OPERATING ACTIVITIES
Net Income	-$108.8M	-$168.0M
YoY Change	512.46%	164.25%
Depreciation, Depletion And Amortization	$3.267M	$10.10M
YoY Change	6.66%	-10.27%
Cash From Operating Activities	-$8.108M	-$40.35M
YoY Change	-6.82%	-9.98%
INVESTING ACTIVITIES
Capital Expenditures	-$133.0K	$5.992M
YoY Change	-110.95%	-47.37%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Cash From Investing Activities	$133.0K	-$5.992M
YoY Change	-110.94%	-76.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$12.34M
YoY Change		-61.47%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	17.22M	$27.68M
YoY Change	6231.62%	-15.05%
NET CHANGE
Cash From Operating Activities	-8.108M	-$40.35M
Cash From Investing Activities	133.0K	-$5.992M
Cash From Financing Activities	17.22M	$27.68M
Net Change In Cash	9.247M	-$18.66M
YoY Change	-195.87%	-50.09%
FREE CASH FLOW
Cash From Operating Activities	-$8.108M	-$40.35M
Capital Expenditures	-$133.0K	$5.992M
Free Cash Flow	-$7.975M	-$46.34M
YoY Change	-19.57%	-17.56%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2024	dei	City Area Code CityAreaCode	1-704
CY2023	akts	Cumulativeeffect Adoption Of Asu201613 CumulativeeffectAdoptionOfASU201613		usd
CY2024	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2024	akts	Operating Leases Liability OperatingLeasesLiability		usd
CY2024	dei	Document Type DocumentType	10-K
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2024	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024	dei	Document Transition Report DocumentTransitionReport	false
CY2024	dei	Entity Registrant Name EntityRegistrantName	AKOUSTIS TECHNOLOGIES, INC.
CY2024	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	33-1229046
CY2024	dei	Entity Address Address Line1 EntityAddressAddressLine1	9805 Northcross Center Court
CY2024	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite A
CY2024	dei	Entity Address City Or Town EntityAddressCityOrTown	Huntersville
CY2024	dei	Entity Address State Or Province EntityAddressStateOrProvince	NC
CY2024	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	28078
CY2024	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value
CY2024	dei	Trading Symbol TradingSymbol	AKTS
CY2024	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024	dei	Entity Small Business EntitySmallBusiness	true
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Public Float EntityPublicFloat	60400000	usd
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	154590918	shares
CY2024	dei	Auditor Firm AuditorFirmId	688
CY2024	dei	Auditor Name AuditorName	Marcum llp
CY2024	dei	Auditor Location AuditorLocation	New York
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24447000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	43104000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	294000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3911000	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4753000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	2223000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	7548000	usd
CY2024Q2	akts	Investment Tax Credit Receivable InvestmentTaxCreditReceivable	3197000	usd
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	2991000	usd
CY2023Q2	us-gaap	Other Assets Current OtherAssetsCurrent	4440000	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	36769000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	59845000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12905000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	57826000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	6508000	usd
CY2023Q2	us-gaap	Goodwill Goodwill	14559000	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	12565000	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	15241000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	923000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1374000	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	71000	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	72000	usd
CY2024Q2	us-gaap	Assets Assets	69741000	usd
CY2023Q2	us-gaap	Assets Assets	148917000	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	16352000	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	17027000	usd
CY2024Q2	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	57372000	usd
CY2024Q2	us-gaap	Notes Payable Current NotesPayableCurrent	10000000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	514000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	439000	usd
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	131000	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	105000	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	84369000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	17571000	usd
CY2024Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	41887000	usd
CY2023Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	43347000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	462000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	976000	usd
CY2023Q2	us-gaap	Other Long Term Notes Payable OtherLongTermNotesPayable	667000	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	117000	usd
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	117000	usd
CY2024Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	42466000	usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	45107000	usd
CY2024Q2	us-gaap	Liabilities Liabilities	126835000	usd
CY2023Q2	us-gaap	Liabilities Liabilities	62678000	usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	175000000	shares
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	175000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	123392181	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	123392181	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	72154647	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	72154647	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	123000	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	72000	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	381289000	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	356522000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-438506000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-270355000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-57094000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	86239000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	69741000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	148917000	usd
CY2024	us-gaap	Revenues Revenues	27384000	usd
CY2023	us-gaap	Revenues Revenues	27121000	usd
CY2024	us-gaap	Cost Of Revenue CostOfRevenue	28073000	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	30237000	usd
CY2024	us-gaap	Gross Profit GrossProfit	-689000	usd
CY2023	us-gaap	Gross Profit GrossProfit	-3116000	usd
CY2024	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	29989000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	33243000	usd
CY2024	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	35884000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	29710000	usd
CY2024	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	8051000	usd
CY2024	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	35378000	usd
CY2024	us-gaap	Operating Expenses OperatingExpenses	109302000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	62953000	usd
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	-109991000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-66069000	usd
CY2024	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2658000	usd
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2322000	usd
CY2023	akts	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	-1446000	usd
CY2024	akts	Contingent Liability On Judgement ContingentLiabilityOnJudgement	-57374000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-8000	usd
CY2024	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2079000	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-948000	usd
CY2024	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-57953000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	64000	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-167944000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-66005000	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2448000	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-167950000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-63557000	usd
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.89
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.89
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	89085992	shares
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	89085992	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63621727	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	63621727	shares
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	103430000	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	32025000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	9407000	usd
CY2023	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	560000	usd
CY2023	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1690000	usd
CY2023	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	2684000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-63557000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	86239000	usd
CY2024	akts	Cumulative Effect Period Of Adoption Adjustment CumulativeEffectPeriodOfAdoptionAdjustment	-201000	usd
CY2024	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	12341000	usd
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	2848000	usd
CY2024	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	66000	usd
CY2024	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	91000	usd
CY2024	akts	Common Stock Issued In Exercise Of Warrants CommonStockIssuedInExerciseOfWarrants	7274000	usd
CY2024	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	2198000	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-167950000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-57094000	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-167950000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-63557000	usd
CY2024	us-gaap	Depreciation And Amortization DepreciationAndAmortization	12759000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	11256000	usd
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	2848000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	9407000	usd
CY2024	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	91000	usd
CY2024	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	619000	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	564000	usd
CY2024	us-gaap	Other Noncash Expense OtherNoncashExpense	2198000	usd
CY2023	us-gaap	Other Noncash Expense OtherNoncashExpense	2684000	usd
CY2024	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-61000	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	100000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2394000	usd
CY2024	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	8051000	usd
CY2024	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	35378000	usd
CY2024	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	451000	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	395000	usd
CY2024	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2079000	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-948000	usd
CY2023	akts	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	-1446000	usd
CY2024	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-641000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	79000	usd
CY2024	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-5325000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3454000	usd
CY2024	akts	Increase Decrease In Other Operating Asset IncreaseDecreaseInOtherOperatingAsset	-1448000	usd
CY2023	akts	Increase Decrease In Other Operating Asset IncreaseDecreaseInOtherOperatingAsset	805000	usd
CY2024	akts	Increase Decrease In Notes Payable IncreaseDecreaseInNotesPayable	2001000	usd
CY2024	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	57371000	usd
CY2024	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1521000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3522000	usd
CY2024	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-439000	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-352000	usd
CY2024	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-667000	usd
CY2023	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	667000	usd
CY2024	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	26000	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-181000	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-40346000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-44821000	usd
CY2024	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5992000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	11385000	usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	121000	usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	13882000	usd
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5992000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-25146000	usd
CY2024	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	12341000	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	32026000	usd
CY2024	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	7274000	usd
CY2024	akts	Proceeds From Employee Stock Purchase Plan ProceedsFromEmployeeStockPurchasePlan	66000	usd
CY2023	akts	Proceeds From Employee Stock Purchase Plan ProceedsFromEmployeeStockPurchasePlan	560000	usd
CY2024	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	8000000	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	27681000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	32586000	usd
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-18657000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-37381000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	43104000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	80485000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24447000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	43104000	usd
CY2024	us-gaap	Interest Paid Net InterestPaidNet	442000	usd
CY2024	us-gaap	Income Taxes Paid IncomeTaxesPaid	7000	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	40000	usd
CY2024	akts	Assets Purchased Using Common Stock AssetsPurchasedUsingCommonStock	2198000	usd
CY2023	akts	Assets Purchased Using Common Stock AssetsPurchasedUsingCommonStock	2684000	usd
CY2024	akts	Fixed Assets Included In Accounts Payable And Accrued Expenses FixedAssetsIncludedInAccountsPayableAndAccruedExpenses	-2194000	usd
CY2023	akts	Fixed Assets Included In Accounts Payable And Accrued Expenses FixedAssetsIncludedInAccountsPayableAndAccruedExpenses	1981000	usd
CY2024	us-gaap	Investment Tax Credit InvestmentTaxCredit	3197000	usd
CY2024	akts	Cumulativeeffect Adoption Of Asu201613 CumulativeeffectAdoptionOfASU201613	-201000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	133000	usd
CY2023	akts	Operating Leases Liability OperatingLeasesLiability	-133000	usd
CY2023	akts	Business Combination Tangible Assets Excluding Cash And Cash Equivalents BusinessCombinationTangibleAssetsExcludingCashAndCashEquivalents	3904000	usd
CY2023Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill	8289000	usd
CY2023Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet	6508000	usd
CY2023Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities	2394000	usd
CY2023Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities	1124000	usd
CY2023	akts	Business Combination Recognized Identifiable Assets Acquired And Liabilities Cancelled BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesCancelled	88000	usd
CY2023	akts	Business Combination Recognized Identifiable Assets Acquired Issuance Of Common Stock For Acquisition BusinessCombinationRecognizedIdentifiableAssetsAcquiredIssuanceOfCommonStockForAcquisition	1690000	usd
CY2024	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 1. Organization</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Akoustis Technologies, Inc. (the “Company”) was incorporated on April 10, 2013, and effective December 15, 2016, the Company changed its state of incorporation to the State of Delaware. Through its wholly-owned subsidiary, Akoustis, Inc. (a Delaware corporation), the Company, headquartered in Huntersville, North Carolina, is focused on developing, designing, and manufacturing innovative radio frequency (“RF”) filter products for the wireless industry, including for products such as smartphones and tablets, cellular infrastructure equipment, Wi-Fi Customer Premise Equipment (“CPE”), and military and defense communication applications. Located between the device’s antenna and its digital backend, the RF front-end (“RFFE”) is the circuitry that performs the analog signal processing and contains components such as amplifiers, filters and switches. To construct the resonator devices that are the building blocks for its RF filters, the Company has developed a family of novel, high purity acoustic piezoelectric materials as well as a unique microelectromechanical system (“MEMS”) wafer semiconductor process, collectively referred to as XBAW® technology. The Company leverages its integrated device manufacturing (“IDM”) business model to develop and sell high performance RF filters using its XBAW® technology. Filters are critical in selecting and rejecting signals, and their performance enables differentiation in the modules defining the RFFE. Additionally, through RFM Integrated Device, Inc. (“RFMi”), a wholly-owned subsidiary of Akoustis, Inc., the Company makes sales of complementary surface acoustic wave (“SAW”) resonators, RF filters, crystal (Xtal) resonators and oscillators, and ceramic products branded as “RFMi” products. We also offer back-end semiconductor supply chain services through our wholly owned subsidiary, Grinding & Dicing Services, Inc. (“GDSI”), which we acquired in January 2023.</p>
CY2024	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2013-04-10
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24400000	usd
CY2024Q2	akts	Working Capital WorkingCapital	46300000	usd
CY2024Q2	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	38600000	usd
CY2024Q3	us-gaap	Professional Fees ProfessionalFees	19	usd
CY2024Q3	us-gaap	Professional Fees ProfessionalFees	19	usd
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Use of estimates and assumptions</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date(s) of the financial statements and the reported amounts of revenues and expenses during the reporting period(s). The policies, estimates and assumptions include estimates and assumptions used in valuation of equity instruments, deferred taxes and related valuation allowances, contingent consideration, goodwill, fair value of the acquired intangible assets, revenue recognition, derivative liabilities, and the fair values of long-lived assets. Actual results could differ from the estimates. </p>
CY2024Q2	us-gaap	Cash Uninsured Amount CashUninsuredAmount	23700000	usd
CY2024	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	pure
CY2024	us-gaap	Number Of Reporting Units NumberOfReportingUnits	2	pure
CY2024Q1	us-gaap	Number Of Reporting Units NumberOfReportingUnits	2	pure
CY2024	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	8100000	usd
CY2024	us-gaap	Asset Impairment Charges AssetImpairmentCharges	35400000	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2022Q3	akts	Refundable Tax Credit Percentage RefundableTaxCreditPercentage	0.25	pure
CY2024	us-gaap	Investment Tax Credit InvestmentTaxCredit	3200000	usd
CY2022Q3	akts	New Book Minimum Tax Percentage NewBookMinimumTaxPercentage	0.15	pure
CY2022Q3	us-gaap	Other Income OtherIncome	1000000000	usd
CY2022Q3	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.01	pure
CY2024	akts	Cumulative Effect Period Of Adoption Adjustment CumulativeEffectPeriodOfAdoptionAdjustment	-201000	usd
CY2024	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	27384000	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	27121000	usd
CY2024	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	70000	usd
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	700000	usd
CY2024Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	1591000	usd
CY2023Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	1574000	usd
CY2024Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	312000	usd
CY2023Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	3741000	usd
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	320000	usd
CY2023Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	2233000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	2223000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	7548000	usd
CY2024	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2800000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	14236000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	84335000	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	645000	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	26509000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12905000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	57826000	usd
CY2024	us-gaap	Depreciation Depreciation	10100000	usd
CY2023	us-gaap	Depreciation Depreciation	9200000	usd
CY2024	akts	Filter Assets FilterAssets	10900000	usd
CY2024	us-gaap	Asset Impairment Charges AssetImpairmentCharges	35400000	usd
CY2024	us-gaap	Number Of Reporting Units NumberOfReportingUnits	2	pure
CY2024	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	8100000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	6500000	usd
CY2023Q2	us-gaap	Goodwill Goodwill	14600000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	18281000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-5716000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	12565000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	18336000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-3095000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	15241000	usd
CY2024	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2600000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2621000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2621000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2522000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2461000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1556000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	784000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	12565000	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3998000	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3979000	usd
CY2024Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	2080000	usd
CY2023Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	4781000	usd
CY2024Q2	akts	Accrued Goods Received Not Invoiced Current AccruedGoodsReceivedNotInvoicedCurrent	618000	usd
CY2023Q2	akts	Accrued Goods Received Not Invoiced Current AccruedGoodsReceivedNotInvoicedCurrent	3700000	usd
CY2024Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	8737000	usd
CY2023Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2248000	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	919000	usd
CY2023Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2319000	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	16352000	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	17027000	usd
CY2024Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	44000000	usd
CY2024Q2	akts	Debt Discount DebtDiscount	-2114000	usd
CY2024Q2	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	1000	usd
CY2024Q2	akts	Carrying Value Of Convertible Notes CarryingValueOfConvertibleNotes	41887000	usd
CY2023Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	44000000	usd
CY2023Q2	akts	Debt Discount DebtDiscount	-2733000	usd
CY2023Q2	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	2080000	usd
CY2023Q2	akts	Carrying Value Of Convertible Notes CarryingValueOfConvertibleNotes	43347000	usd
CY2023Q2	us-gaap	Debt Instrument Redemption Price Percentage DebtInstrumentRedemptionPricePercentage	1	pure
CY2024	us-gaap	Debt Instrument Redemption Price Percentage DebtInstrumentRedemptionPricePercentage	1.50	pure
CY2024	akts	Common Stock Conversion Price Consecutive Day CommonStockConversionPriceConsecutiveDay	P20D
CY2024	akts	Common Stock Conversion Price Consecutive Trading Day CommonStockConversionPriceConsecutiveTradingDay	P30D
CY2024	akts	Weighted Average Price Common Stock For Trading Days WeightedAveragePriceCommonStockForTradingDays	P10D
CY2024	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	8000000	usd
CY2024Q2	akts	Sales Agreement SalesAgreement	21000000	usd
CY2022Q2	akts	Remains Available Of Common Stock Sold RemainsAvailableOfCommonStockSold	48000000	usd
CY2023Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	2.75
CY2023Q1	akts	Underwritten Offering Of Common Stock Shares UnderwrittenOfferingOfCommonStockShares	1636363	shares
CY2023Q1	us-gaap	Sale Leaseback Transaction Gross Proceeds Financing Activities SaleLeasebackTransactionGrossProceedsFinancingActivities	34500000	usd
CY2023Q1	us-gaap	Noninterest Expense Offering Cost NoninterestExpenseOfferingCost	2500000	usd
CY2023Q1	us-gaap	Demutualization By Insurance Entity Securities Issued Amount Of Net Proceeds DemutualizationByInsuranceEntitySecuritiesIssuedAmountOfNetProceeds	32000000	usd
CY2024Q1	us-gaap	Partners Capital Account Units Sold In Public Offering PartnersCapitalAccountUnitsSoldInPublicOffering	23000000	shares
CY2024Q1	us-gaap	Sale Leaseback Transaction Gross Proceeds Financing Activities SaleLeasebackTransactionGrossProceedsFinancingActivities	11500000	usd
CY2024Q1	akts	Underwriting Discount And Offering Expenses underwritingDiscountAndOfferingExpenses	1100000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	10400000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	1000000	usd
CY2024Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.2
CY2024Q2	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	10000000	usd
CY2024Q2	akts	Fee And Offering Expense FeeAndOfferingExpense	800000	usd
CY2024Q2	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	9200000	usd
CY2024	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	31000000	usd
CY2018Q4	us-gaap	Partners Capital Account Units Sold In Public Offering PartnersCapitalAccountUnitsSoldInPublicOffering	3000000	shares
CY2019Q3	us-gaap	Convertible Preferred Stock Shares Reserved For Future Issuance ConvertiblePreferredStockSharesReservedForFutureIssuance	6000000	shares
CY2022Q4	us-gaap	Convertible Preferred Stock Shares Reserved For Future Issuance ConvertiblePreferredStockSharesReservedForFutureIssuance	12000000	shares
CY2024Q2	us-gaap	Convertible Preferred Stock Shares Reserved For Future Issuance ConvertiblePreferredStockSharesReservedForFutureIssuance	3614154	shares
CY2024	akts	Stock Option Granted Percentage StockOptionGrantedPercentage	0.10	pure
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P5Y
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0	pure
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3156037	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.61
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	263500	shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.59
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	566183	shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	7.71
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2853354	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.83
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y8M23D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2199404	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	6.08
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P2Y14D
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested	0	usd
CY2024	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2848000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9407000	usd
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	700000	usd
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	3500000	usd
CY2024	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	2900000	usd
CY2024	akts	Share Based Compensation Arrangement By Share Based Payment Award Restricted Shares ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedShares	550000	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	7.6
CY2018Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.85	pure
CY2023Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	1
CY2024	us-gaap	Stockholders Equity Average Amount Outstanding StockholdersEquityAverageAmountOutstanding	2500000	usd
CY2024	us-gaap	Operating Lease Expense OperatingLeaseExpense	601000	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	519000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	923000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1374000	usd
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	514000	usd
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	439000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	462000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	976000	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y1M13D
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y11M19D
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1298	pure
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1277	pure
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	606000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	374000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	66000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	68000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	11000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1125000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	149000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	976000	usd
CY2018Q1	us-gaap	Area Of Land AreaOfLand	9.995	sqm
CY2018Q1	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	12000000	usd
CY2024	akts	Benefits Of Contingencies BenefitsOfContingencies	400000	usd
CY2024Q2	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	38600000	usd
CY2024Q2	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability	57400000	usd
CY2024	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	100000	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	100000	usd
CY2024	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	6000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-38000	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-16000	usd
CY2024	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	6000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-54000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-2179000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-215000	usd
CY2023	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	-2394000	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2448000	usd
CY2024	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0141	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0135	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.0082	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.0156	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.007	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.0121	pure
CY2024	akts	Effective Income Tax Rate Reconciliation Goodwillimpairment EffectiveIncomeTaxRateReconciliationGoodwillimpairment	-0.0101	pure
CY2023	akts	Effective Income Tax Rate Reconciliation Goodwillimpairment EffectiveIncomeTaxRateReconciliationGoodwillimpairment	0	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.0053	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.2152	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.1915	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.0037	pure
CY2024	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0371	pure
CY2024Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	64644000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	53755000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3576000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	4373000	usd
CY2024Q2	akts	Deferred Tax Assets Tax Credit DeferredTaxAssetsTaxCredit	-5132000	usd
CY2023Q2	akts	Deferred Tax Assets Tax Credit DeferredTaxAssetsTaxCredit	-3753000	usd
CY2024Q2	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	9257000	usd
CY2023Q2	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	8145000	usd
CY2024Q2	akts	Deferred Tax Assets Contingent Liability DeferredTaxAssetsContingentLiability	12880000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	932000	usd
CY2024Q2	akts	Deferred Tax Assets Accumulated Depreciationbasis Differences DeferredTaxAssetsAccumulatedDepreciationbasisDifferences	517000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	497000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1387000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	97435000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	71413000	usd
CY2024Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	2735000	usd
CY2023Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	3338000	usd
CY2023Q2	akts	Deferred Tax Liabilities Accumulated Depreciationbasis Differences DeferredTaxLiabilitiesAccumulatedDepreciationbasisDifferences	9945000	usd
CY2024Q2	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	425000	usd
CY2024Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3160000	usd
CY2023Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	13283000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	94275000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	58130000	usd
CY2024Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	34200000	usd
CY2024Q2	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	261000000	usd
CY2024Q2	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	5100000	usd
CY2024	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	36100000	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	12600000	usd
CY2023Q2	akts	Gross Unrecognized Tax Benefits GrossUnrecognizedTaxBenefits	700000	usd
CY2024Q2	akts	Gross Unrecognized Tax Benefits GrossUnrecognizedTaxBenefits	500000	usd
CY2023Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued	700000	usd
CY2024Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued	500000	usd
CY2023Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	541000	usd
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	427000	usd
CY2024	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	106000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	70000	usd
CY2024	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	47000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	44000	usd
CY2024Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	694000	usd
CY2023Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	541000	usd
CY2024Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	694000	usd
CY2024	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	pure
CY2024	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	43195179	shares
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	12497862	shares
CY2024	akts	Pre Funded Warrant PreFundedWarrant	31000000	usd
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024	dei	Local Phone Number LocalPhoneNumber	997-5735
CY2023Q2	akts	Investment Tax Credit Receivable InvestmentTaxCreditReceivable		usd
CY2023Q2	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent		usd
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent		usd
CY2024Q2	us-gaap	Other Long Term Notes Payable OtherLongTermNotesPayable		usd
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2023	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges		usd
CY2024	akts	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration		usd
CY2023	akts	Contingent Liability On Judgement ContingentLiabilityOnJudgement		usd
CY2024	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2023	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
CY2024	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2023	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges		usd
CY2024	akts	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration		usd
CY2023	akts	Increase Decrease In Notes Payable IncreaseDecreaseInNotesPayable		usd
CY2023	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities		usd
CY2024	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
CY2024	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		usd
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2023	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt		usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023	us-gaap	Investment Tax Credit InvestmentTaxCredit		usd
CY2024	akts	Business Combination Tangible Assets Excluding Cash And Cash Equivalents BusinessCombinationTangibleAssetsExcludingCashAndCashEquivalents		usd
CY2024Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill		usd
CY2024Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet		usd
CY2024Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities		usd
CY2024Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities		usd
CY2024	akts	Business Combination Recognized Identifiable Assets Acquired And Liabilities Cancelled BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesCancelled		usd
CY2024	akts	Business Combination Recognized Identifiable Assets Acquired Issuance Of Common Stock For Acquisition BusinessCombinationRecognizedIdentifiableAssetsAcquiredIssuanceOfCommonStockForAcquisition		usd
CY2024	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue		usd
CY2023	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices		usd
CY2024	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2024	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		usd
CY2024	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2024	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit		usd
CY2023Q2	akts	Deferred Tax Assets Contingent Liability DeferredTaxAssetsContingentLiability		usd
CY2023Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory		usd
CY2023Q2	akts	Deferred Tax Assets Accumulated Depreciationbasis Differences DeferredTaxAssetsAccumulatedDepreciationbasisDifferences		usd
CY2024Q2	akts	Deferred Tax Liabilities Accumulated Depreciationbasis Differences DeferredTaxLiabilitiesAccumulatedDepreciationbasisDifferences		usd
CY2023Q2	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther		usd
CY2024Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2024	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions		usd
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions		usd
CY2024	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations		usd
CY2023	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations		usd
CY2024	dei	Amendment Flag AmendmentFlag	false
CY2024	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2024	dei	Entity Central Index Key EntityCentralIndexKey	0001584754

Files In Submission

Name	View Source	Status
0001213900-24-085984-index-headers.html	Edgar Link	pending
0001213900-24-085984-index.html	Edgar Link	pending
0001213900-24-085984.txt	Edgar Link	pending
0001213900-24-085984-xbrl.zip	Edgar Link	pending
akts-20240630.xsd	Edgar Link	pending
ea0209774-10k_akoustis.htm	Edgar Link	pending
ea020977401ex21-1_akoustis.htm	Edgar Link	pending
ea020977401ex23-1_akoustis.htm	Edgar Link	pending
ea020977401ex31-1_akoustis.htm	Edgar Link	pending
ea020977401ex31-2_akoustis.htm	Edgar Link	pending
ea020977401ex32-1_akoustis.htm	Edgar Link	pending
ea020977401ex32-2_akoustis.htm	Edgar Link	pending
ea020977401ex97-1_akoustis.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
akts-20240630_cal.xml	Edgar Link	unprocessable
akts-20240630_def.xml	Edgar Link	unprocessable
akts-20240630_lab.xml	Edgar Link	unprocessable
akts-20240630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ea0209774-10k_akoustis_htm.xml	Edgar Link	completed
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
image_005.jpg	Edgar Link	pending
image_006.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AKTSQ
Akoustis Technologies, Inc. Stock $aktsq

2024 Q4 Form 10-K Financial Statement

#000121390024085984 Filed on October 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AKTSQ Akoustis Technologies, Inc. Stock $aktsq

2024 Q4 Form 10-K Financial Statement

#000121390024085984 Filed on October 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AKTSQ
Akoustis Technologies, Inc. Stock $aktsq